Emerging evidence highlights the superiority of online cognitive behavioural therapy as the primary treatment for social anxiety disorder, with long-term benefits comparable to in-person therapy, and evolving approaches integrating medication, psychodynamic therapy, and health factors.
Social anxiety disorder is common, often persistent, and highly treatable, but the evidence suggests that not all approaches perform equally well. Across recent reviews, cognitive behavioural therapy has emerged as the clearest first choice, with long-term benefits that extend beyond symptom relief to depression, general anxiety and overall quality of life. In one meta-analysis cited by PubMed, those gains were still evident a year after treatment ended, underlining why CBT remains the standard against which other options are measured.
That advantage appears to hold whether therapy is delivered in person or online. A systematic review in the Wiley journal Clinical Psychology & Psychotherapy found that internet-based CBT reduced social anxiety symptoms substantially and performed comparably with face-to-face treatment, with benefits maintained at six and 12 months. For people who struggle to attend sessions regularly, that makes remote CBT a practical alternative rather than a weaker substitute.
The picture becomes more complicated when social anxiety sits alongside other conditions. The Psychology Today summary notes that depression is a frequent companion diagnosis, and research has found internet-delivered CBT can still work well in those cases, while also reducing depressive symptoms. By contrast, patients with both social anxiety and alcohol use disorder tend to carry heavier psychiatric burdens and are less likely to stick with treatment, which is one reason clinicians are urged to look carefully for comorbidities before deciding on a plan.
Other psychotherapies may still have a role, especially when CBT is unavailable, poorly tolerated or only partially effective. A recent meta-analysis cited by the source article identified psychodynamic therapy as the strongest non-CBT option, while another found no clear difference between psychodynamic therapy and CBT. Exposure-based work, social skills training, self-help approaches, cognitive bias modification and mindfulness can all help some patients, but they generally rank below CBT and psychodynamic therapy. Some targeted adaptations may improve results further: one PubMed review found that imagery-enhanced cognitive behavioural group therapy produced better outcomes than standard group treatment, and another review noted that mindfulness-based stress reduction may improve sleep more effectively than group CBT for patients whose sleep is disrupted.
Medication remains important, particularly when symptoms are severe or therapy is inaccessible, but it is not usually the first-place recommendation. According to the material cited by Psychology Today, selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors are commonly used first-line drugs, although side effects are frequent. A meta-analysis reported paroxetine as the most effective drug versus placebo, but the same evidence suggested that overall drug-placebo differences were modest. Other agents, including pregabalin at higher doses, may have a place in specialist care, while several other medicines have produced mixed or weak results.
There is also growing interest in biological contributors to social anxiety, including the gut microbiome. Research published in PubMed has found differences in gut composition and function between people with social anxiety and healthy controls, and the Psychology Today piece notes that fermented foods containing probiotics have been associated with fewer symptoms. That does not yet make diet a stand-alone treatment, but it points to a broader shift in the field: social anxiety is increasingly being treated as a condition best managed through a combination of proven psychotherapy, selective medication use and attention to the wider health factors that can shape recovery.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.





